Controlling directed protein interaction networks in cancer

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Kanhaiya, Krishna ^a   Czeizler, Eugen ^a,b   Gratie, Cristian ^a   Petre, Ion ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT IN MICROTECHNOLOGIES   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BIOLOGICAL MODEL; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PROCEDURES; PROTEIN ANALYSIS; PROTEOMICS; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

ALGORITHMS; DATABASES, GENETIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 85028819988     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10491-y     Document Type: Article

References (80)

1. Richard, S., & Brugge, S. J. Signal transduction in cancer. Cold Spring Harbor Perspectives in Medicine 5, a006098-A006098 (2015
2. Yoshimura, A. Signal transduction of inflammatory cytokines and tumor development. Cancer Science 97, 439-447 (2006
3. Pawson, T., & Nash, P. Protein-protein interactions define specificity in signal transduction. Genes & Dev. 31(4), 1027-1047 (2000
4. Wrana, J. L. Signaling by the tgf-beta superfamily. Cold Spring Harbor Perspectives in Biology 5, a011197-A011197 (2013
5. Mu, Y., Gudey, S. K., & Landström, M. Non-smad signaling pathways. Cell and Tissue Research 347, 11-20 (2011
6. Elston, R., & Inman, G. J. Crosstalk between p53 and TGF-beta signalling. Journal of Signal Transduction 2012, 1-10 (2012
7. Pawson, T., & Warner, N. Oncogenic re-wiring of cellular signaling pathways. Oncogene 26, 1268-1275 (2007
8. Amit, I., Wides, R., & Yarden, Y. Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy. Molecular Systems Biology 3 (2007
9. Xu, A. M., & Huang, P. H. Receptor tyrosine kinase coactivation networks in cancer. Cancer Research 70, 3857-3860 (2010
10. Kolch, W., Halasz, M., Granovskaya, M., & Kholodenko, B. N. The dynamic control of signal transduction networks in cancer cells. Nature Reviews Cancer 15, 515-527 (2015
11. Menche, J., et al. Uncovering disease-disease relationships through the incomplete interactome. Science 347, 1257601-1257601 (2015
12. Shim, J. E., & Lee, I. Network-Assisted approaches for human disease research. Animal Cells and Systems 19, 231-235 (2015
13. Goh, K.-I., & Choi, I.-G. Exploring the human diseasome: the human disease network. Briefings in Functional Genomics 11, 533-542 (2012
14. Goh, K.-I., et al. The human disease network. Proceedings of the National Academy of Sciences 104, 8685-8690 (2007
15. Erler, J. T., & Linding, R. Network-based drugs and biomarkers. The Journal of Pathology n/a-n/a (2009
16. Farkas, I. J., et al. Network-based tools for the identification of novel drug targets. Science Signaling 4, pt3-pt3 (2011
17. Korcsmáros, T., Szalay, M. S., Böde, C., Kovács, I. A., & Csermely, P. How to design multi-Target drugs. Expert Opinion on Drug Discovery 2, 799-808 (2007
18. Csermely, P., Agoston, V., & Pongor, S. The efficiency of multi-Target drugs: the network approach might help drug design. Trends in Pharmacological Sciences 26, 178-182 (2005
19. Clatworthy, A. E., Pierson, E., & Hung, D. T. Targeting virulence: a new paradigm for antimicrobial therapy. Nature Chemical Biology 3, 541-548 (2007
20. Zhan, T., & Boutros, M. Towards a compendium of essential genes - from model organisms to synthetic lethality in cancer cells. Critical Reviews in Biochemistry and Molecular Biology 51, 74-85 (2015
21. Wang, T., et al. Identification and characterization of essential genes in the human genome. Science 350, 1096-1101 (2015
22. Pyatnitskiy, M., Karpov, D., Poverennaya, E., Lisitsa, A., & Moshkovskii, S. Bringing down cancer aircraft: Searching for essential hypomutated proteins in skin melanoma. PLOS ONE 10, e0142819 (2015
23. Gao, J., Liu, Y.-Y., D?Souza, R. M., & Barabási, A.-L. Target control of complex networks. Nature Communications 5, 5415 (2014
24. Zañudo, J. G. T., & Albert, R. Cell fate reprogramming by control of intracellular network dynamics. PLOS Computational Biology 11, e1004193 (2015
25. Liu, Y.-Y., Slotine, J.-J., & Barabási, A.-L. Controllability of complex networks. Nature 473, 167-173 (2011
26. Wuchty, S. Controllability in protein interaction networks. Proceedings of the National Academy of Sciences 111, 7156-7160 (2014
27. Khuri, S., & Wuchty, S. Essentiality and centrality in protein interaction networks revisited. BMC Bioinformatics 16 (2015
28. Hofmann, B. T., et al. COSMC knockdown mediated aberrant o-glycosylation promotes oncogenic properties in pancreatic cancer. Molecular Cancer 14 (2015
29. Koh, J. L. Y., et al. Colt-cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Research 40(Database issue), D957-D963 (2012
30. Czeizler, E., Gratie, C., Chiu, W. K., Kanhaiya, K., & Petre, I. Target Controllability of Linear Networks, 67-81 (Springer Nature, 2016
31. Yu, H., et al. High-quality binary protein interaction map of the yeast interactome network. Science 322, 104-110 (2008
32. He, X., & Zhang, J. Why do hubs tend to be essential in protein networks? PLoS Genetics 2, e88 (2006
33. Barabási, A.-L., & Oltvai, Z. N. Network biology: understanding the cell?s functional organization. Nature Reviews Genetics 5, 101-113 (2004
34. Yu, H., Kim, P. M., Sprecher, E., Trifonov, V., & Gerstein, M. The importance of bottlenecks in protein networks: Correlation with gene essentiality and expression dynamics. PLoS Computational Biology 3, e59 (2007
35. Badache, A., & Gonçalves, A. The ErbB2 signaling network as a target for breast cancer therapy. Journal of Mammary Gland Biology and Neoplasia 11, 13-25 (2006
36. Gao, S., et al. Overexpression of ErbB2 renders breast cancer cells susceptible to 3-BrPA through the increased dissociation of hexokinase-II from mitochondrial outer membrane. Oncology Letters (2015
37. Balko, J., Mayer, I., Levy, M., & Arteaga., C. Her2 (erbb2) overexpression in breast cancer (2014
38. Carmona, F. J., et al. AKT signaling in ERBB2-Amplified breast cancer. Pharmacology & Therapeutics 158, 63-70 (2016
39. Finn, R. S. Targeting src in breast cancer. Annals of Oncology 19, 1379-1386 (2008
40. Sen, B., & Johnson, F. M. Regulation of src family kinases in human cancers. Journal of Signal Transduction 2011, 1-14 (2011
41. Falasca, M., & Fyffe, C. 3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer. Cancer Management and Research 271 (2013
42. Maurer, M., et al. 3-phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Research 69, 6299-6306 (2009
43. Cimino, D., et al. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues. International Journal of Cancer 123, 1327-1338 (2008
44. Wheler, J. J., et al. Multiple gene aberrations and breast cancer: lessons from super-responders. BMC Cancer 15 (2015
45. Zhou, Z., et al. Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening. BMC Cancer 14 (2014
46. Paplomata, E., & O?Regan, R. The PI3k/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Therapeutic Advances in Medical Oncology 6, 154-166 (2014
47. Kolb, A., et al. Expression and differential signaling of heregulins in pancreatic cancer cells. International Journal of Cancer 120, 514-523 (2006
48. Skrypek, N., et al. The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2. Oncotarget 6, 10853-10867 (2015
49. Kelber, J. A., et al. KRas induces a src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Research 72, 2554-2564 (2012
50. Albury, T. M., et al. Constitutively active akt1 cooperates with KRasG12d to accelerate in vivo pancreatic tumor onset and progression. Neoplasia 17, 175-182 (2015
51. Shi, P., et al. Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3k/akt signaling pathway. BMC Cancer 14 (2014
52. Marchand, B., Arsenault, D., Raymond-Fleury, A., Boisvert, F.-M., & Boucher, M.-J. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells. Journal of Biological Chemistry 290, 5592-5605 (2015
53. Jacobs, K. M., et al. GSK-3: A bifunctional role in cell death pathways. International Journal of Cell Biology 2012, 1-11 (2012
54. Kim, G. P., & Billadeau, D. D. GSK-3beta Inhibition in Pancreatic Cancer, 635-646 (Springer Nature, 2008
55. Angelescu, R., et al. Abl1 mrna levels in pancreatic cancer and chronic pancreatitis. Annals of RSCB 17, 246-250 (2012
56. Greuber, E. K., Smith-Pearson, P., Wang, J., & Pendergast, A. M. Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nature Reviews Cancer 13, 559-571 (2013
57. Levav-Cohen, Y., et al. C-Abl as a modulator of p53. Biochemical and Biophysical Research Communications 331, 737-749 (2005
58. Yasuo, I., et al. Expression of the wild type rearranged during transfection protooncogene in ovarian cancer (originals). Jikeikai Med J (2011
59. Horio, M., et al. Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer. Cancer Medicine 1, 218-229 (2012
60. Ma, Y., et al. Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo. Laboratory Investigation 96, 37-48 (2015
61. Zaman, V., et al. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell reports 5, 216-213 (2013
62. Wang, E., et al. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Seminars in cancer biology 30, 4-12 (2015
63. Wang, E., et al. Cancer systems biology in the genome sequencing era: Part 2, evolutionary dynamics of tumor clonal networks and drug resistance. Seminars in cancer biology 23, 286-292 (2013
64. UniProt: a hub for protein information. Nucleic Acids Research 43, D204-D212 (2014
65. Aka, J. A., & Lin, S.-X. Comparison of functional proteomic analyses of human breast cancer cell lines t47d and MCF7. PLoS ONE 7, e31532 (2012
66. Lee, K. M., et al. Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling. Breast Cancer Research 16 (2014
67. Britton, D., et al. Quantification of pancreatic cancer proteome and phosphorylome: Indicates molecular events likely contributing to cancer and activity of drug targets. PLoS ONE 9, e90948 (2014
68. Haun R. S., Fan C. Y., Mackintosh S. G., Zhao H., & Tackett A. J. Cd109 overexpression in pancreatic cancer identified by cell-surface glycoprotein capture. Journal of Proteomics & Bioinformatics 20, 317-330 (2014
69. Shahinian, H., et al. Secretome and degradome profiling shows that kallikrein-related peptidases 4, 5, 6, and 7 induce TGFbeta-1 signaling in ovarian cancer cells. Molecular Oncology 8, 68-82 (2013
70. Bell, D., et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011
71. Domcke, S., Sinha, R., Levine, D. A., Sander, C., & Schultz, N. Evaluating cell lines as tumour models by comparison of genomic profiles. Nature Communications 4 (2013
72. Perfetto, L., et al. SIGNOR: a database of causal relationships between biological entities. Nucleic Acids Research 44, D548-D554 (2015
73. COMBIO. Network controlability project. http://combio.abo.fi/research/network-controlability-project/.(2016
74. Marcotte, R., et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discovery 2, 172-189 (2011
75. Wishart, D. S., et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research 36, D901-D906 (2007
76. Kalman, R. E. Mathematical description of linear dynamical systems. Journal of the Society for Industrial and Applied Mathematics Series A Control 1, 152-192 (1963
77. CT, L. Structural controllability. IEEE Trans. Automat. Contr 19, 201-208 (1974
78. Murota, K., Poljak, S., & of Applied Mathematics, U. K. D. Note on a Graph-Theoretic Criterion for Structural Output Controllability. KAM series, discrete mathematics and combinatorics, operations research, mathematical linguistics (Department of Applied Mathematics, Charles University, 1989
79. Blackhall, L., & Hill, D. J. On the structural controllability of networks of linear systems. IFAC Proceedings Volumes 43, 245-250 (2010
80. Vinayagam, A., et al. Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets. Proceedings of the National Academy of Sciences 113, 4976-4981 (2016